Yunkai Lin
No. 700 Moyu North Road
Jiadingzhen, 201800, China
Jiadingzhen, 201800, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
RPRD1A drives lenvatinib resistance in hepatocellular carcinoma via the ITGA5-FAK signaling axis.
Journal: Molecular biomedicine
Published: November 07, 2025
LAMC2 promotes gallbladder carcinoma metastasis through the TGF-β pathway.
Journal: Cancer cell international
Published: May 27, 2025
The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer.
Journal: Signal transduction and targeted therapy
Published: March 29, 2025
Mechanism exploration of Zoledronic acid combined with PD-1 in the treatment of hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: September 21, 2023
Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Journal: Frontiers in immunology
Published: February 15, 2023
URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers.
Journal: Nature communications
Published: December 26, 2022
The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma.
Journal: Cell death & disease
Published: January 16, 2022
SIRPα maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis.
Journal: EBioMedicine
Published: August 17, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026